Investing Profile

Sharon Shacham

VCInvestor
Co-Founder and Managing Director at E44 Ventures
e44ventures.earth/about/Tel Aviv, Israel
Photo of Sharon Shacham, Managing Partner at E44 Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Tel Aviv University Network
191 CONNECTIONS
Tel Aviv University Network
191 CONNECTIONS
cb
E44 Ventures Managing Partner
$1M - $5.0M
$2.0M
1
CompanyStageDateRound SizeTotal Raised
phelas
SeedMar 2024$4M
$4M
Co-investors: Rune Theill (HubSpot), Harry Gilbert (BP Ventures)
SVP Drug Development EPIX PharmaceuticalsPresent
Director, Algorithm and Software Development Predix PharmaceuticalsPresent
Scientific Advisory Board Member Karyopharm Therapeutics Inc.Present
President and CSO Karyopharm Therapeutics Inc.Present
Chief Scientific Officer Karyopharm Therapeutics Inc.Present
Board Member Acrivon Therapeutics, Inc.Present
Scientific and Clinical Advisor Sporos BioventuresPresent
Board Member Merlin HealthPresent
Scientific Advisor ProtaiPresent
Board Member AgriPass RoboticsPresent
Board Observer CarbonadePresent
Board Observer GigabluePresent
Advisory Board phelasPresent
CEO and President Karyopharm Therapeutics Inc.Present
Founder Karyopharm Therapeutics Inc.Present
Co-Founder Polaroid TherapeuticsPresent
Co-Founder and Managing Director E44 VenturesPresent
Tel Aviv University PhD Biochemistry and Computational Biophysics
Tel Aviv University MBA Information Systems